C-reactive protein and homocysteine predict long-term mortality in young ischemic stroke patients

Halvor Naess1, Harald Nyland, Titto Idicula

  • 1Department of Neurology, Haukeland University Hospital, Bergen, Norway.

Insights

In young ischemic stroke survivors, elevated C-reactive protein (CRP) and homocysteine levels predict long-term mortality. These inflammatory markers are independent predictors of death, even after accounting for traditional risk factors.

Area of Science:

  • Neurology
  • Cardiovascular Research
  • Inflammation Studies

Background:

  • Investigated the relationship between C-reactive protein (CRP) and homocysteine levels and subsequent mortality in young ischemic stroke patients.
  • Utilized a population-based study design for comprehensive analysis.

Purpose of the Study:

  • To determine the long-term prognostic value of CRP and homocysteine in young ischemic stroke survivors.
  • To assess the independence of this association from traditional cardiovascular risk factors.

Main Methods:

  • Followed-up young ischemic stroke patients for an average of 6 years post-stroke.
  • Measured CRP and homocysteine levels, recorded risk factors (myocardial infarction, diabetes, hypertension, smoking, alcoholism, cancer), and assessed stroke outcome using the modified Rankin Scale.
  • Analyzed subsequent survival data from the population registry using Cox regression.

Main Results:

  • 198 young ischemic stroke patients (mean age 47.8 years) were included; 36 (18.2%) died during a mean follow-up of 12.4 years.
  • Mortality was significantly associated with CRP (HR 1.05; P=.001) and homocysteine levels (HR 1.04; P=.02) in patients without dissection.
  • Kaplan-Meier curves demonstrated increasing separation in survival rates based on dichotomized CRP and homocysteine levels.

Conclusions:

  • CRP and homocysteine levels measured years after ischemic stroke in young adults are independently associated with subsequent mortality.
  • This association persists for at least 12 years post-measurement, highlighting their long-term prognostic significance.
  • Findings emphasize the role of inflammation and homocysteine in long-term outcomes for young stroke survivors.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...